TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8916980

Group type: EXPERIMENTAL
Intervention: GnRH agonist plus add-back hormone replacement therapy (HRT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 25 micrograms oestradiol patches plus continuous medroxyprogesterone acetate (5 mg)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Full bone-sparing dose of oral oestradiol (2 mg daily)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Gonadomimetic tibolone
Number of subjects: 3
Study: 1988635

Group type: EXPERIMENTAL
Intervention: Miniature cesium iodide/photodiode nuclear probe (Cardioscint)
Number of subjects: 77
Study: 6761854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Methenamine hippurate
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Trimethoprim
Number of subjects: 290
Study: 6547543

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Pirenzepine
Number of subjects: 37
Study: 31200649

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic‐hyperoxic training (IHHT) combined with multimodal training intervention (MTI)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Multimodal training intervention (MTI) alone (Normoxic Group)
Number of subjects: 34
Study: 29074068

Group type: EXPERIMENTAL
Intervention: IV metoclopramide 20mg + diphenhydramine 25mg
Number of subjects: 21
Study: 30408383

Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate combined with Gonadotropin-Releasing Hormone (GnRH) analog
Number of subjects: 34

Group type: COMPARATOR
Intervention: Depot Medroxyprogesterone Acetate alone
Number of subjects: 34
Study: 25252482

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no Tamsulosin)
Number of subjects: 120
Study: 22506940

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) with 1 mg IV morphine on-demand doses
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) with 1.5 mg IV morphine on-demand doses
Number of subjects: 211

Group type: COMPARATOR
Intervention: Non-PCA treatment (initial dose of 0.1 mg/kg IV morphine followed by physician-managed analgesia)
Number of subjects: 211
Study: 21490985

Group type: EXPERIMENTAL
Intervention: Lift-off debonding instrument
Number of subjects: 37

Group type: COMPARATOR
Intervention: Ligature-cutting plier
Number of subjects: 37
Study: 18076256

Group type: EXPERIMENTAL
Intervention: 1-hour HBO exposure inspiring 100% O2 at 202.6 kPa (2.0 ATA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 1-hour sham exposure inspiring ambient air at 121.5 kPa (1.2 ATA)
Number of subjects: 18
Study: 15683500

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metoprolol 200 mg/day
Number of subjects: 100
Study: 12521623

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 10827329

Group type: EXPERIMENTAL
Intervention: Standardized vascular clinic (SVC) experience (4 hours)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Traditional ambulatory experience (4 hours)
Number of subjects: 124
Study: 8675589

Group type: EXPERIMENTAL
Intervention: Parenteral estrogen (im polyestradiol phosphate, 240 mg twice monthly)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Parenteral testosterone (im injections, 250 mg/week)
Number of subjects: 23
Study: 2060433

Group type: EXPERIMENTAL
Intervention: Intensified health education (IHE)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Clofibric acid
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: IHE group
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: IHE plus clofibric acid group
Number of subjects: 1139
Study: 6359109

Group type: EXPERIMENTAL
Intervention: Propranolol (non‐cardioselective, no ISA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pindolol (non‐cardioselective, high ISA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Labetalol (non‐cardioselective, alpha‐blocker)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 30
Study: 31274334

Group type: EXPERIMENTAL
Intervention: Honey Bee Venom (HBV)
Number of subjects: 538

Group type: COMPARATOR
Intervention: Control (histamine)
Number of subjects: 538
Study: 28490560

Group type: EXPERIMENTAL
Intervention: Team-care deprescribing practice using a deprescribing guide (Beers and STOPP criteria, drug interaction checking)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Team-care deprescribing practice
Number of subjects: 0
Study: 25655950

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 16

Group type: COMPARATOR
Intervention: MDMA
Number of subjects: 16
Study: 24400934

Group type: EXPERIMENTAL
Intervention: Strength training (STRENGTH)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Stretching (STRETCH)
Number of subjects: 57
Study: 23034965

Group type: EXPERIMENTAL
Intervention: Long-chain n-3 PUFAs (3.36 g/d)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (butterfat equivalent)
Number of subjects: 55
Study: 19664750

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control
Number of subjects: 157
Study: 17963164

Group type: EXPERIMENTAL
Intervention: Continue GC treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Withdraw GC treatment
Number of subjects: 58
Study: 15167190

Group type: EXPERIMENTAL
Intervention: Addition of a second physician during the evening shift
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (patients managed by internal medicine residents before the addition of a second physician)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (emergency department inpatients admitted for hospitalization)
Number of subjects: 360
Study: 12173164

Group type: EXPERIMENTAL
Intervention: Music intervention during colonoscopy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 32
Study: 10580204

Group type: EXPERIMENTAL
Intervention: CAIV-T
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: TIV
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 8753947

Group type: EXPERIMENTAL
Intervention: Young adults (Experiment 1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Older adults (Experiment 2)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Probable Alzheimer's disease patients (Experiment 3)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Children aged 5-6, 9-11, and 14-16 years (Experiment 4)
Number of subjects: 77
Study: 1809445

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg each night for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6308754

Group type: EXPERIMENTAL
Intervention: Mecillinam (200 mg daily for 25 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 29842903

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 177

Group type: COMPARATOR
Intervention: HIV disease self‐management skills group (Control)
Number of subjects: 177
Study: 27414687

Group type: EXPERIMENTAL
Intervention: Hypoxia group (seven passive 1-h exposures to normobaric hypoxia)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (sham hypoxia)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hypoxia group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 23145830

Group type: EXPERIMENTAL
Intervention: Communication with an outgroup audience
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heightened salience of intergroup competition
Number of subjects: 0
Study: 23748920

Group type: EXPERIMENTAL
Intervention: apixaban 2.5 mg BID
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: apixaban 5 mg BID
Number of subjects: 151

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 151
Study: 20555286

Group type: EXPERIMENTAL
Intervention: Mixed-Intensity Interval Endurance-Training (MI-ET) program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Endurance-Training (ET) program
Number of subjects: 32
Study: 17939152

Group type: EXPERIMENTAL
Intervention: Test product (huperzine A 0.2 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference product (huperzine A 0.2 mg)
Number of subjects: 18
Study: 16125805

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) training for 8 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 12924680

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control (no MI)
Number of subjects: 208
Study: 11012094

Group type: EXPERIMENTAL
Intervention: Docetaxel-based regimens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Doxorubicin-based regimens
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Serum c-erbB2 measurements
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patients with positive tissue staining
Number of subjects: 30
Study: 8885067

Group type: EXPERIMENTAL
Intervention: Early intervention program providing long-term medical care and social work services (1991-1993 cohort)
Number of subjects: 868

Group type: COMPARATOR
Intervention: No early intervention services (1989 cohort)
Number of subjects: 868

Group type: EXPERIMENTAL
Intervention: Early intervention program (1991-1993 cohort)
Number of subjects: 868

Group type: EXPERIMENTAL
Intervention: Prevalent gonorrhea condition at the time of HIV diagnosis
Number of subjects: 868

Group type: EXPERIMENTAL
Intervention: Failure to return for scheduled post-HIV+ test counseling
Number of subjects: 868

Group type: EXPERIMENTAL
Intervention: Active gonorrhea screening (1991-1993 period)
Number of subjects: 868
Study: 1506533

Group type: EXPERIMENTAL
Intervention: Tapping in synchrony with the perceived structure of Gaussian noise samples
Number of subjects: 9
Study: 2414844

Group type: EXPERIMENTAL
Intervention: Transurethral prostatectomy (TURP)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Transvesical prostatectomy (TVP)
Number of subjects: 75
Study: 31892650

Group type: EXPERIMENTAL
Intervention: Tailored prehabilitation programme (patient education and exercise for 6-12 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tailored prehabilitation programme
Number of subjects: 150
Study: 29394348

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg/day for 4 weeks
Number of subjects: 247

Group type: COMPARATOR
Intervention: No intervention (non-statin users)
Number of subjects: 247
Study: 26725583

Group type: EXPERIMENTAL
Intervention: Nefopam 20 mg intravenous (i.v.) 30 min before surgery, followed by an i.v. infusion (5 mg/h) for 24 h
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nefopam group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (normal saline)
Number of subjects: 42
Study: 24719175

Group type: EXPERIMENTAL
Intervention: Vitamin D levels (measured via DiaSorin radioimmunoassay)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Vitamin D levels
Number of subjects: 82
Study: 23220812

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham dry needling (placebo)
Number of subjects: 52
Study: 20350159

Group type: EXPERIMENTAL
Intervention: Xenogeneic collagen matrix (CM) with coronally advanced flap (CAF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) with coronally advanced flap (CAF)
Number of subjects: 25
Study: 18534331

Group type: EXPERIMENTAL
Intervention: Higher strength 180 mT magnetic bracelets
Number of subjects: 116

Group type: COMPARATOR
Intervention: Weak 50 mT magnetic bracelets
Number of subjects: 116
Study: 15372064

Group type: EXPERIMENTAL
Intervention: Sodium reduction (comprehensive education and counselling about how to reduce sodium intake)
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 1159

Group type: COMPARATOR
Intervention: Usual care (no dietary intervention)
Number of subjects: 1159
Study: 12891223

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rofecoxib (25 mg daily)
Number of subjects: 12
Study: 10525564

Group type: EXPERIMENTAL
Intervention: Oral L-arginine (50 mg/kg body weight)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8666597

Group type: EXPERIMENTAL
Intervention: Two-incision reconstruction with autogenous semitendinosus-gracilis graft (Group I)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Two-incision reconstruction with autogenous patellar-ligament graft (Group II)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Single-incision reconstruction (endoscopic technique) with autogenous patellar-ligament graft (Group III)
Number of subjects: 127
Study: 8381932

Group type: EXPERIMENTAL
Intervention: Angiotensin II (ANGII) infusion after pretreatment with lithium 750 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Hyperinsulinaemic euglycaemic clamp in 7 non-diabetic subjects
Number of subjects: 25
Study: 3113242

Group type: EXPERIMENTAL
Intervention: Misoprostol (800 micrograms in two or four divided doses daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study: 29202887

Group type: EXPERIMENTAL
Intervention: 100-KGM (no pasta and all KGM-gel, 322 kJ (77 kcal))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50-KGM (half pasta and half KGM-gel, 1084 kJ (259 kcal))
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (all pasta, 1849 kJ (442 kcal))
Number of subjects: 16
Study: 27560971

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 26540313

Group type: EXPERIMENTAL
Intervention: Re-reading own description before identification task
Number of subjects: 208

Group type: COMPARATOR
Intervention: No description (control group)
Number of subjects: 208
Study: 23542419

Group type: EXPERIMENTAL
Intervention: Comprehensive exercise training (aerobic, resistance, and balance training) 3 times/week for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stretching with minimal muscle strengthening stimuli 3 times/week for 6 months
Number of subjects: 30
Study: 21988614

Group type: EXPERIMENTAL
Intervention: FT (new prefilled insulin pen)
Number of subjects: 242
Study: 19583931

Group type: EXPERIMENTAL
Intervention: Xuesaitong Injection (400 mg in 250 mL 5% glucose injection, administered once daily for 6 days post-operation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (conventional anti-infection and transfusion treatment)
Number of subjects: 50
Study: 17081902

Group type: EXPERIMENTAL
Intervention: True acupuncture starting 20 minutes before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham acupuncture starting 20 minutes before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: No acupuncture
Number of subjects: 75
Study: 15021850

Group type: EXPERIMENTAL
Intervention: Self-report questionnaires and interview
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Clinician rating
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Cyclosporine levels
Number of subjects: 153

Group type: COMPARATOR
Intervention: Electronic monitoring
Number of subjects: 153
Study: 11359221

Group type: EXPERIMENTAL
Intervention: Regional block with 18 mL of 1% ropivacaine and oral mexiletine for the first 6 postoperative days (R + M group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Regional block and placebo (R + PL group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline instead of ropivacaine and mexiletine (PL + M group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline and placebo (PL + PL group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study: 10636072

Group type: EXPERIMENTAL
Intervention: High-dose combined hepatitis A and B vaccine (720 E1.U HAV antigen; 20 microg HBsAg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Twinrix Paediatric (360 E1.U HAV antigen; 10 microg HBsAg)
Number of subjects: 100
Study: 8635828

Group type: EXPERIMENTAL
Intervention: 1 mg vitamin K intramuscularly
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 2 mg vitamin K orally
Number of subjects: 51

Group type: COMPARATOR
Intervention: No vitamin K
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Oral vitamin K
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin K
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Vitamin K (either form)
Number of subjects: 51
Study: 2697625

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline 0.5 mg via a spacer
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1097840

Group type: EXPERIMENTAL
Intervention: 4 units of platelets (Group I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No platelets (Group II)
Number of subjects: 60
Study: 31709997

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 28857855

Group type: EXPERIMENTAL
Intervention: Letter of condolence
Number of subjects: 52
Study: 24714530

Group type: EXPERIMENTAL
Intervention: Lower limb compression tights for 72 hours after the marathon run
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham treatment group received a single treatment of 15 minutes of sham ultrasound after the marathon run
Number of subjects: 24
Study: 23664268

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 or 2 mA for 20 min, anode over the left dorsolateral prefrontal cortex, cathode right supraorbital cortex)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham tDCS (placebo)
Number of subjects: 22
Study: 20572473

Group type: EXPERIMENTAL
Intervention: VRDSRT (Virtual Reality Driving Simulation Rehabilitation Training)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Residential rehabilitation only (Control)
Number of subjects: 11
Study: 17854995

Group type: EXPERIMENTAL
Intervention: Oral sucrose (25%; 0.5 ml/kg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 33
Study: 16005496

Group type: EXPERIMENTAL
Intervention: Dexamethasone 3 mg twice daily for 5 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 24
Study: 12834787

Group type: EXPERIMENTAL
Intervention: Mixed lunch (MIX)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-fat lunch (HF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-carbohydrate lunch (HCHO)
Number of subjects: 36
Study: 10787444

Group type: COMPARATOR
Intervention: Baseline diet (BL) - 39% kcal fat, 164 mg cholesterol/1000 kcal
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High trans stick margarine (SM)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low trans squeeze margarine (SQM)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Medium trans tub margarine (TM)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Soybean oil (SO)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Butter (BT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High fat baseline diet (BL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: ASR-FC
Number of subjects: 14
Study: 2107563

Group type: EXPERIMENTAL
Intervention: Recombinant human tissue-type plasminogen activator (rt-PA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Urokinase (UK)
Number of subjects: 32
Study: 313245

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant high-dose methotrexate with leucovorin rescue
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette‐Guérin by a multiple‐puncture technique
Number of subjects: 39

Group type: COMPARATOR
Intervention: Historical control patients treated with surgery alone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Current patients with grade III and IV lesions
Number of subjects: 39
Study: 30736826

Group type: EXPERIMENTAL
Intervention: Yokukansan
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 27307057

Group type: EXPERIMENTAL
Intervention: Didactic teaching plus standardized patient simulation
Number of subjects: 94

Group type: COMPARATOR
Intervention: Didactic teaching alone
Number of subjects: 94
Study: 25315960

Group type: EXPERIMENTAL
Intervention: 1-step posterior reconstruction technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard technique)
Number of subjects: 100
Study: 24393593

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.42 (Tetraspan)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Tetrastarch vs. crystalloid or albumin (systematic review)
Number of subjects: 798
Study: 21902857

Group type: EXPERIMENTAL
Intervention: Lean red meat (lamb)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lean white meat (chicken)
Number of subjects: 36
Study: 19015835

Group type: EXPERIMENTAL
Intervention: Exercise (10 min moderate-intensity stationary cycling)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (passive seating for same duration)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Post-exercise
Number of subjects: 10
Study: 17239066

Group type: EXPERIMENTAL
Intervention: Acupressure treatment for 4 weeks, 15 minutes, twice a day, five days a week.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control treatment (companionship and conversation) for 4 weeks after a treatment-free period.
Number of subjects: 31
Study: 15898865

Group type: COMPARATOR
Intervention: Assessment-only arm of a clinical trial
Number of subjects: 112